Menactra Vaccine

Menactra Vaccine

Therapeutic Class:
Manufacturer:
Get Quote

Menactra Vaccine is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C,Y and W-135. It is approved for use in individuals 9 months through 55 years of age.

Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.

Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, loss of appetite, sleepiness, headache, nausea, vomiting, and diarrhea. If these side effects do not go away with time or get worse, let the doctor know. The doctor may help with ways to reduce or prevent these symptoms.

To make sure the vaccine is safe, before receiving the vaccine, it is important to let the doctor know if you have any other illnesses. You should also tell the doctor about all the medicines you are taking. Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.

Salt Composition: Meningococcal Vaccine (Group A, C, Y & W-135) + Diphtheria Toxoid
Strength: (16mcg) + (48mcg)
Pack Size: 1.0 Solution for Injection in 1 vial
Uses: Prevention of Meningococcal disease
Table Header
Salt Composition
Meningococcal Vaccine (Group A, C, Y & W-135) + Diphtheria Toxoid
Strength
(16mcg) + (48mcg)
Pack Size
1.0 Solution for Injection in 1 vial
Uses
Prevention of Meningococcal disease
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Menactra Vaccine which is also known as Meningococcal Vaccine (Group A, C, Y & W-135) + Diphtheria Toxoid and Manufactured by Sanofi India Ltd. It is available in strength of (16mcg) + (48mcg) is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:
×